Screening versus diagnostic testing
The purpose of a test changes the evidence it needs. Compare screening, investigation of symptoms and follow-up of an abnormal result before evaluating a claim.
Screening looks for a condition before relevant symptoms appear. Diagnostic testing investigates a suspected problem, including a symptom or an abnormal screening result. The same technology can serve different purposes, so a claim that a test “finds disease” needs more context before it can support a screening offer.
The National Cancer Institute's screening overview explains that an abnormal cancer screening result generally needs diagnostic follow-up. A positive screen alone does not establish a cancer diagnosis; a normal result cannot explain away a new symptom.
Identify the question the test is answering
This comparison is an editorial way to read a test offer, not a decision about your own eligibility.
| Context | Question to clarify | Information to request |
|---|---|---|
| No relevant symptoms; offered screening | Which condition and population is this programme intended for? | Eligibility criteria and evidence of benefit and harms |
| A symptom or suspected condition | What specific clinical question is being investigated? | The clinician's reasoning and what the result could change |
| An abnormal screening result | What further assessment is needed to understand the finding? | A follow-up plan and who will take responsibility for it |
Descriptions such as “comprehensive”, “advanced” or “preventive” do not answer these questions. Read the stated purpose rather than inferring it from the package name.
Detection is one outcome, not the whole verdict
NCI identifies false positives, false negatives and overdiagnosis among the problems that screening can create. It also explains why finding cancer earlier does not automatically mean that a screening programme helps people live longer. Those are cancer-screening principles, not evidence that every wellness test is ineffective.
For any claim, ask the seller or clinician to distinguish what has been measured from what is being promised. A higher detection rate is a different statement from fewer serious illnesses or deaths. A claim should identify the study population, comparison and outcome rather than joining those statements together.
A claim-reading card
Copy these five prompts when comparing an offer:
- What is the target condition, and why is this test being offered to me?
- Does the cited study concern people without symptoms or patients already being investigated?
- Which outcome was measured: findings, further procedures or health outcomes?
- What happens if the result is abnormal or uncertain, and who arranges the follow-up?
- Which uncertainties remain, and where can I read the evidence?
The NCI overview of screening tests separates tests with established benefits in defined settings from other tests whose benefits remain under study. Eligibility and frequency depend on the specific test and guideline; this page does not prescribe a universal screening schedule.
Put the distinction to work
Compare the purpose described in the offer with the purpose studied in its evidence. If they differ, ask for the missing explanation before treating the study as proof of the offer.
For a worked review, see whole-body MRI without symptoms. For the wider approach to evaluating claims, read how this site handles evidence.
Sources checked on 30 September 2026. This comparison and question card are editorial tools, not individual screening advice or a licensed clinical review.
Related reading
For a specific offer, use the evidence reading worksheet to record what was studied and what remains unknown. The absolute and relative risk explainer shows how to read a percentage claim with its baseline and time frame.
Sources
Applying the evidence
A verdict about a claim is not an individual screening plan. Read the screening guide and discuss your history, prior results and possible follow-up with a qualified clinician.